SolarBank Corp. (SUUN) Taps Data Center Veteran Jonathan Martone to Guide Data Center Market Expansion

Thumzup Media Corp. (TZUP) Continues to Boost Client Numbers, Using AI to Speed Innovation

ESGold Corp. (ESAUF) Advances Subsurface Imaging to Expand Montauban Project Potential

Torr Metals Inc. (TMET): Strategic Exploration in Established Mining Districts

Nutriband Inc. (NASDAQ: NTRB) Is ‘One to Watch’

Repros Therapeutics, Inc. (NASDAQ: RPRX)

November 3, 2008 at 5:14am

Repros Therapeutics, Inc. (NASDAQ: RPRX) is focused on developing oral small molecule drugs to treat substantial, but unmet medical needs. The company has a proven track-record of rapidly progressing their therapeutic candidates through clinical development with efficiency. Proellex, the company’s lead drug, selectively blocks the progesterone receptor and may treat uterine fibroids, endometriosis and anemia associated with uterine fibroids. For further information, visit the Company’s web site at www.reprosrx.com.

Archives

Select A Month

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.